Interactive Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,033
Closed -$633K 88
2024
Q4
$633K Sell
7,033
-44
-0.6% -$4.26K 0.33% 51
2024
Q3
$699K Sell
7,077
-273
-4% -$26.8K 0.36% 47
2024
Q2
$681K Sell
7,350
-150
-2% -$13.4K 0.38% 45
2024
Q1
$712K Buy
7,500
+4,159
+124% +$386K 0.39% 43
2023
Q4
$584K Sell
3,341
-4,087
-55% -$304K 0.31% 47
2023
Q3
$542K Sell
7,428
-259
-3% -$20.7K 0.37% 45
2023
Q2
$640K Sell
7,687
-941
-11% -$78.7K 0.43% 44
2023
Q1
$658K Buy
8,628
+156
+2% +$12.9K 0.42% 43
2022
Q4
$703K Buy
8,472
+506
+6% +$41K 0.42% 46
2022
Q3
$632K Buy
7,966
+65
+0.8% +$5.48K 0.37% 47
2022
Q2
$598K Buy
7,901
+1,383
+21% +$104K 0.3% 44
2022
Q1
$585K Sell
6,518
-333
-5% -$30.8K 0.27% 52
2021
Q4
$767K Buy
6,851
+427
+7% +$51.5K 0.29% 48
2021
Q3
$808K Buy
6,424
+357
+6% +$46K 0.35% 46
2021
Q2
$821K Buy
6,067
+134
+2% +$17.6K 0.33% 46
2021
Q1
$805K Sell
5,933
-222
-4% -$33.2K 0.34% 45
2020
Q4
$867K Sell
6,155
-420
-6% -$53.8K 0.39% 42
2020
Q3
$733K Sell
6,575
-258
-4% -$28.9K 0.36% 41
2020
Q2
$765K Buy
6,833
+114
+2% +$11.2K 0.38% 37
2020
Q1
$520K Sell
6,719
-863
-11% -$76.4K 0.46% 26
2019
Q4
$721K Buy
7,582
+6
+0.1% +$519 0.32% 42
2019
Q3
$578K Sell
7,576
-28
-0.4% -$2.33K 0.27% 42
2019
Q2
$667K Buy
+7,604
New +$649K 0.31% 40

Other funds holding XBI

Interactive Financial Advisors's XBI Position: Q1 2025 in Review

Interactive Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 7,033 shares — an estimated $633K sold.

Interactive Financial Advisors first reported a position in XBI in Q2 2019 and held it in 23 quarters. The position peaked at $867K in Q4 2020. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Interactive Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Interactive Financial Advisors sold 7,033 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $633K.
  • Interactive Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and held it in 23 quarters.
  • Interactive Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $867K in Q4 2020.
  • 685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Interactive Financial Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.